BRIEF-Gilead Antiviral Drug Remdesivir Flops In First Trial - FT

* GILEAD ANTIVIRAL DRUG REMDESIVIR FLOPS IN FIRST TRIAL - FT

* CHINESE TRIAL SHOWED REMDESIVIR DID NOT IMPROVE PATIENTS’ CONDITION OR REDUCE THE PATHOGEN’S PRESENCE IN THE BLOODSTREAM - FT * REMDESIVIR, HAS FLOPPED IN ITS FIRST RANDOMISED CLINICAL TRIAL, ACCORDING TO DRAFT DOCUMENTS PUBLISHED ACCIDENTALLY BY THE WHO - FT

* GILEAD WARNED THAT THE DRAFT DOCUMENT POSTED ACCIDENTALLY BY WHO INCLUDED “INAPPROPRIATE CHARACTERISATIONS OF THE STUDY”- FT Source text: https://on.ft.com/2Vxsc1c Further company coverage: